BioLargo, Inc. · OTC:BLGO
BioLargo — Shareholder Meeting (June 2024)
49 slides from BioLargo's shareholder meeting presentation, Jun 13, 2024
Slide 1: BioLargo Annual Stockholder Meeting 2024
) BioLargo We Make Life Better Better Solutions for: Air - Water —- Energy Annual Stockholder Stock Symbol: Meeting 2024 BLGO
Slide 2: Safe Harbor Statement
Safe Harbor Statement
Slide 3: Who we are
Who we are > Innovators, > Passionate about > Driven by a mission scientists, engineers, sustainability and to make life better and entrepreneurs human health
Slide 4: What we do
What we do > Best-in-class > Engineering-forward > Focus on problems solutions for technologies without good cleantech problems solutions
Slide 5: Operating Segments
Operating Segments Commercializing our Technologies The BioLargo Innovation Engine GQ Beker0° BioLargo | |) CLYR4'| ENERGY We Make Life Better BioLargo =. = AVEENVIRONWENTAL a (elem 5
Slide 6: Revenue (Past Years)
$ MILLIONS $40 $0 $100 $80 $60 $40 820 REVENUE (PAST 6 YEARS) 2ore 2018 Trends are not necessory indicative of future performance (Bietarg0
Slide 7: Quarterly Revenue and SG&A
ONS Mi QUARTERLY REVENUE AND SG&A Qi Q2. 3 Qt Qt 2 Qs 2022 2023 as a 2024 Key highlights from Q1 2024: Revenue: * Ql was $4,760,000, an increase of $390,000 over Q48 $4,370,000 * 99% quarter-over-quarter increase + 28% increase compared to Qi 2023 Cash generated from operating activities: + Qi cash
Slide 8: 2024 Revenue Run Rate Scenarios
$20 $18 $16 $4 $12 $10 2024 REVENUE RUN RATE SCENARIOS , 2018 2019 2020 2021 2022 2023 2024 Current revenue run rate * Q1 2024 revenue was $4,760,000 * Our current annual revenue run rate is $19 million Trends are not necessarily indicative of future performance, and future revenues are highly depen
Slide 9: Net Stockholder's Equity
6 $5 NET STOCKHOLDER'S EQUITY | $5.1M 2018 2019 2021 2022 2023 1 0F 2028 Trends are not necessarily indicative of future performance (Bictarg0
Slide 10: Why we know we will win... big!
Why we know we will win... big! 1. Purpose 2. People 3. Technology 4. Strategy (Bictargo 10
Slide 11: ONM Environmental Products and Services
__ ©" \O___ CINMEENVIRONMENTAL RODUCTS AND SERVICES CN nce CupriDyne’ POOPH (Couciean @ Awholy onredsubsiny of (Biotec |
Slide 12: Slide 12
Slide 13: Slide 13
Slide 14: New POOPH Products
NEW POOPH PRODUCTS (Requested by Major Retailers) * Wipes Litterizer Puppy Pads
Slide 15: Major Retail Outlets
Major Retail Outlets RR Walmart>'< BRS [alave prime i ioe
Slide 16: POOPH - Consumer pet odor product
POOPH - Consumer pet odor product - Product marketed and sold by our partners, award-winning ; consumer product experts (Ikigai Marketing Works) é ONM receives manufacturer's margin and a royalty on sales Business strategy: ramp up sales and sell to a major consumer products company + ONM would rece
Slide 17: Pooph - Looking Forward
Pooph - Looking Forward * Fantastic historic performance * Pooph's goals: * Continued 20% QoQ growth + 80,000 stores + Wipes and Litterizer both launched + Puppy Pads coming soon! * Ongoing discussions about expanding product category
Slide 18: ONM Industrial Segment
ONM Industrial Segment Automotive (paint emissions) Wastewater Treatment 1. Municipal Solid Rendering Waste Food Processing Cte CJL Asphalt Manufacturing > Customers include largest waste handlers in the country, County of Orange, Santa Barbara County, LA County, Miami-Dade County, City of Los Angel
Slide 19: BioLargo
(yBiotargo 19
Slide 20: Summary
Summary NVIRONMENTAL MN One underlying chemistry technology Industrial and Consumer portfolios Both profitable Historic trends expected to continue pee |
Slide 21: Clyra Medical: A Breakthrough Solution for Infection Control
A Breakthrough Solution For Infection Control Cc W R A better science better outcomes 2024 is the Year that Preparation Meets Opportunity A partially owned subsidiary of sBiokargo cya Medical 2008 BioLor
Slide 22: Market Opportunities and Business Strategy
Market Opportunities and Business Strategy © CR” The Clyra Antimicrobial Solution + Apiatform with numerous applications in healthcare ane + Non-cytatoxic, non-staining, non-sensitizing, non damaging to tissue In Wound Irrigation * Effective versus biofilms, broad spectrum, long-lasting efficacy A N
Slide 23: Progress Made, Capital Invested
Progress Made, Capital Invested Preparing for scaled manufacturing Keystone Industries Two new surgical products Equipment purchased Molds made Our investment - $1 million
Slide 24: Commercialization Update for Technologies and Market Solutions
=. BioLargo = EQUIPMENT = SOLUTIONS = TECHNOLOGIES Commercialization Update for Technologies and Market Solutions Awholl owned subsidiary of
Slide 25: Products
Products ‘ovanced Oxidation System Bi
Slide 26: PFAS: the Forever Chemicals Plaguing Water Supplies
PFAS: the “Forever Chemicals” Plaguing Water Supplies Around the World of sites — including tary base: a lustral plants — across the U! d |
Slide 27: AEC Carbon Filtration / Media Filtration
BAEC © CARBON FILTRATION/ MEDIA FILTRATION
Slide 28: AEC PFAS Tech Progress
AEC PFAS Tech Progress * First AEC sold, being installed Fall 2024 *11+ successful customer water an trials * Regulatory certifications in process * Mobile pilot unit available (item | a
Slide 29: Lake Stockholm
Lake Stockholm System in Fabrication * Four skids now in fabrication * Completion and FAT test scheduled for August 2024 * Shipping to the site in September (GBiobargo
Slide 30: Business Development Highlights
Business Development Highlights * Continued expansion of selling organization * New opportunities constantly * Garratt-Callahan update (AROS): * Major data center and pharma company interest * 4 customer pilots completed + New PFAS markets, potentially faster to adopt: « Wastewater + Leachate + AFFF
Slide 31: 2024 Goals
2024 Goals + Successfully complete our first commercial AEC installation * Secure more projects * Complete regulatory certifications * Advance PFAS tech for use in other markets * Commitments for field pilots in water, wastewater, and leachate * Raise government awareness of our solution (sBiotargo
Slide 32: Other regulatory drivers for PFAS
Other regulatory drivers for PFAS HAZARDOUS WASTE (Biota 2
Slide 33: Engineering, Science & Technologies
Engineering , Science & Technologies CO} BioLargo ineering Team Focus: + Internal product development * Support product commercialization + External client projects (Bict2rgo By
Slide 34: BLEST's role as BioLargo's engineers
BLEST's role as BioLargo's engineers * AEC Technology + Battery Technology + PFAS Destruction Technology * Leachate and AFFF + External contracts
Slide 35: US Air Force Contract Update
US Air Force (USAF) Contract Update In addition to ongoing air compliance support contracts at six USAF bases, since 2019 * Three New Mexico bases, two Texas bases, up to 5 years and $3.5 million in revenue) * In the running for more bases and revenues * More proposals in the works * Note — revenue
Slide 36: BioLargo Water Canada
OBioLargo Water = ( BioLargo Canada ~ 2024 Annual Stockholder Meeting Richard Smith, Ph.D. BioLargo Canada June 13, 2024 jv
Slide 37: Canada
Canada b BioLargo AOS NT semersonetinsyaam, & eX + $400K in grant funding committed, expected to be received over next 18 months * Two major grant/project proposals outstanding for >$4 million e CLYRA + Leveraging science expertise, grant funding, and collaboration to advance commercial success (20L
Slide 38: AOS Spiral Version
AOS Spiral Version 2 Version 1 Version 2 * Alive, future role of importance as Targeting grant-funded micropollutant trials: regulations get tighter + Switzerland + Improved residence time * SAIT (Alb * Dependenton * Higher current density (Alberta) fepencion * Lower CAPX and OPEX * on-site requirem
Slide 39: Cellinity Teaser Video
Cellinity Teaser Video
Slide 40: BioLargo Liquid Sodium Battery: Cellinity
BioLargo Liquid Sodium Battery: \OO} C=LLINITY BY BIOLARGO ENERGY TECHNOLOGIES
Slide 41: Commercialization Pathway
Commercialization Pathway — BioLargo k EN=RGY TECHNOLOGIES i ket worth billions Scale up cells Build component Complete pilot and battery manufacturing manufacturing packs facility Make and Make licensing Engage with partners test cells partnerships as consulting engineer and licensing partner to bu
Slide 42: Target markets
Target markets What do they have in common? Static, large-format energy storage uses Renewable energy storage Grid-scale storage / grid leveling EV charging stations Residential backup power stations for homes, businesses, hospitals, etc. | > | Emergency response / disaster relief
Slide 43: Government incentives helping drive adoption
Government incentives helping drive adoption: 45X tax credit for grid-scale battery manufacturers Investment Tax Credit (ITC) for battery projects US Treasury and IRS provide additional guidance for 45X manufacturing tax credit for (Bote | a
Slide 44: Initially targeting two SKU sizes
Initially targeting two SKU sizes 1MWh ~25 KWh of tT] 2 GBioter¢o
Slide 45: Cellinity Core Value Propositions
—— seat ‘CURRENT coLLecTors ELECTRODE Cellinity Core Value Propositions |_— separator (Beta-Alumina) _— NecaTive —~ ELECTRODE liguid Na} CELL CASE GBeteme | s
Slide 46: Business Model: Sell Factories, Not Batteries
Business Model: Sell Factories, Not Batteries + Enabling Microgrid deployment 19 OF + Lev us tax incentive + Embrace underserved communities + Generating revenue for our design, build + Financed by our Partners
Slide 47: Why this model?
Why this model? What the community gets * The best grid-scale battery technology available * Workforce development for local community * Ownership and financial benefits of factory What BioLargo gets * Scalable, practical rollout of our battery technology + Balance sheet friendly strategy * Diverse,
Slide 48: First Battery Cells Now Manufactured
First Battery Cells Now Manufactured BioLargo Manufactures First Cellinity Battery Cells, a Safer Alternative to Lithium-ion WESTMINSTER, CA / ACCESSWIRE / June 11,2024 /BioLargo, Inc. (OTCQX:BLGO), a company that ereate ccommercializs sustainable echnologies to solve tough environmental and cleante
Slide 49: The BioLargo Family of Companies
The BioLargo Family of Companies BioLargo, Inc. isa sustainable science, technology & full-service enviromental engineering company that makes lifebetter by delivering world-class products and services acrossa broad range of industries, witha drive to deliver clean water, clean ai, and advanced anti